ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co - Wikidata - wikimedia - TriplyDB

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

http://www.wikidata.org/entity/Q34971421

about

Anticoagulation therapy versus placebo for pulmonary hypertension Anticoagulation therapy versus placebo for pulmonary hypertension Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies The Wonders of Phosphodiesterase-5 Inhibitors: A Majestic History Inhaled pulmonary vasodilators for persistent pulmonary hypertension of the newborn: safety issues relating to drug administration and delivery devices Sphingosine kinase 1/sphingosine 1-phosphate signalling pathway as a potential therapeutic target of pulmonary hypertension The molecular targets of approved treatments for pulmonary arterial hypertension Right heart on multidetector CT.Obesity: physiologic changes and implications for preoperative management Interdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologists Pulmonary vascular mechanics: important contributors to the increased right ventricular afterload of pulmonary hypertension Portopulmonary hypertension: an update The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)Optimal management of pulmonary arterial hypertension: prognostic indicators to determine treatment course Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate Inhaled therapy for the management of perioperative pulmonary hypertension Right ventricular adaptation and failure in pulmonary arterial hypertension.A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy Whole-exome sequencing reveals TopBP1 as a novel gene in idiopathic pulmonary arterial hypertension Changes in large pulmonary arterial viscoelasticity in chronic pulmonary hypertension 4-Phenylbutyric Acid Induces Protection against Pulmonary Arterial Hypertension in Rats Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Doppler echocardiography inaccurately estimates right ventricular pressure in children with elevated right heart pressure MRI catheterization in cardiopulmonary disease Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.Characterization of CMR-derived haemodynamic data in children with pulmonary arterial hypertension.Peripheral pulmonary artery stenosis as a cause of pulmonary hypertension in adults Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers.Presence and outcomes of kidney disease in patients with pulmonary hypertension Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.Impact of the removal of the monthly liver function test requirement for ambrisentan.Pharmacotherapy in pulmonary arterial hypertension: a systematic review and meta-analysis Prognostic value of echocardiographic changes in patients with pulmonary arterial hypertension receiving parenteral prostacyclin therapy.Identifying "super responders" in pulmonary arterial hypertension.Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA Pulmonary function differences in patients with chronic right heart failure secondary to pulmonary arterial hypertension and chronic left heart failure Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine.

P2860

Q24194138-7253202C-C628-44EF-AA9A-EEFE74F81445 Q24200875-3127746F-7BA0-46C0-8A42-7F8182D41760 Q26738405-4B47B5C5-F49E-4470-8AFE-B9285418ECFD Q26741387-77FD7A49-0ED3-49DB-9385-EF1E42278A79 Q26750702-504566ED-31A2-4B18-A228-D6D6A96C0506 Q26778497-8011F8B1-1D10-4DFE-86FB-90B86E98C63F Q26798308-81A602A0-5930-401A-BFD7-450B0810ABE5 Q26830102-2C9254D1-ADC3-48BB-B5BF-6CF4F8A1251B Q26830911-0C2575C0-50B7-43B6-830E-3E7DBEFFB968 Q26860314-395DF3EB-262A-493F-AEBD-BADC857650D5 Q26862662-FDFC9619-F367-4102-9B9A-712C38A8061C Q27000393-A9ED19F7-6122-4734-8744-7DEF992FC48F Q27013946-15A4559E-4CCD-4627-BEE9-F6C13C27E2B1 Q27023074-7F2520D8-03F0-4EA3-9F63-DDCA89EB676A Q27024293-2761201A-3EA7-4DFA-A924-8B7298CF8965 Q27026465-56B9516E-D84A-4DB3-823B-0F90E0D1C605 Q27026522-8C851441-4A29-43BD-8255-69F334B358AB Q27318422-32F7B071-1F70-4BC6-972B-CC57CB4370DB Q28072562-D7FC2066-660B-41C8-8236-6DC7170D2573 Q28237461-F29AF4E9-D7F9-4FD9-AD06-C9FDC477ACF2 Q28534877-382B02E2-7BEA-4638-A1E7-4CA6A48C87CC Q28550288-B463E2B2-5DCC-4FC0-8D0A-9E87EF59EB23 Q30364647-995F3F06-9C1C-40F3-A2AA-8F003977FF52 Q30419778-D863D35C-C14A-439B-AFA8-B4B9A0E64717 Q30421631-B7B33221-EE08-4FE1-8369-7B00F5C9E082 Q30429733-C88BF52F-A6B7-4D4A-A7A3-3F49D097C5FD Q30435973-5213C0B6-C856-4DEA-AC3A-05E5C2693377 Q31116579-9123B318-3FEC-46E5-A505-00C3BE61CC54 Q33165753-52BAB14A-0656-4FFC-8C72-B744538A221B Q33166775-D69488E0-7655-400C-8379-D23890871B10 Q33430964-FE931BD9-6D21-42D8-B7EA-9C62EEC76CF4 Q33571852-1C6E1A41-3AE6-45EC-86A7-2D12FA96AC00 Q33681073-E00FA86E-3289-479C-B1AC-272F0AD14A54 Q33714798-7DD98417-B0AE-493B-B1FD-47A2B71A2DA5 Q33715766-475CC063-1D39-40A2-AF32-0C86471A0515 Q33787275-DD59C9FA-9341-4683-8BC9-528A811BE5B2 Q33788452-04329014-B863-4DC0-8C5A-F3F7BB92863E Q33788468-49F6D660-0B94-4581-B5E8-776E870A4BA4 Q33793953-1DA25400-D4EF-4477-B811-EB97447D4F80 Q33803027-4561698C-8797-42ED-A26B-383D6BDBE3A5

P2860

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co

http://www.wikidata.org/entity/Q34971421

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@ast

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@en

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@nl

type

label

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@ast

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@en

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@nl

prefLabel

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@ast

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@en

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@nl

P1433

Q34971421-621779F7-A3D0-4B07-903A-066B4C9189DD

P1476

Q34971421-3BF44239-57B0-4325-8FF2-99CF55144883

P2093

Q34971421-00B9C9A4-DD14-4A13-995E-966EECC30F91

Q34971421-024736F7-DB48-4B33-BB3B-8C5D7971787C

Q34971421-07D45D17-1B56-4816-815A-593B9C4ED2F7

Q34971421-0C904E30-2081-42C2-A3CC-AC01BCC4CA89

Q34971421-1D2F84A8-4C7C-41F8-8B44-0ACAFDAEB987

Q34971421-20988E80-E60F-4F8E-905B-7D305F3ED56D

Q34971421-2170EB0B-014B-4AF0-A05A-680DC5BAD3D9

Q34971421-228AB042-E222-4124-B909-56C818DC80F3

Q34971421-234159CD-1137-41E4-AACE-765BF2BAF74D

Q34971421-2F177865-2F98-4CA6-8EFB-6F01C3755738

P304

Q34971421-E9202FDA-2281-49E7-8087-647C5047ACDC

P31

Q34971421-42277371-98DD-45C4-AC91-EAB9B02604B0

P356

Q34971421-68AFA74A-6B07-48DA-BBC0-662A6E82D05A

P407

Q34971421-EC7D6A0A-2C2B-489F-AC8D-C1EDE87DC290

P433

Q34971421-19F17D44-0F93-4BD9-8CDA-4AAAFE385EE5

P478

Q34971421-BA6ABFB8-9A3D-4C6E-A92D-58E9FC42197B

P50

Q34971421-06EB1B89-074E-491D-BBD4-7C11E5135956

Q34971421-31B5EC3B-DB69-42B0-A369-9B6A8DB45A1B

Q34971421-4ACDF89F-CA70-4F27-BF62-16C5BF63324B

Q34971421-E08DEBF8-170E-41A3-A810-9B48EA96C70B

Q34971421-EA1E88EA-0FA1-4133-9E75-E778239709D7

P577

Q34971421-36A9FF60-625F-4DF9-BF0F-54BC0A2B121F

P698

Q34971421-0F4969C5-3DE3-4E1D-A69C-2217D87CE88F

P921

Q34971421-86DAD805-27E8-440D-BBFD-8FFE34BDCCDD

P356

CIRCULATIONAHA.109.192230

P1433

P1476

ACCF/AHA 2009 expert consensus ...... aboration with the American Co

@en

P2093

ACCF/AHA

http://www.w3.org/2001/XMLSchema#string

Charles R Bridges

http://www.w3.org/2001/XMLSchema#string

Cindy L Grines

http://www.w3.org/2001/XMLSchema#string

Cynthia M Tracy

http://www.w3.org/2001/XMLSchema#string

David B Badesch

http://www.w3.org/2001/XMLSchema#string

Debabrata Mukherjee

http://www.w3.org/2001/XMLSchema#string

Deborah J Wesley

http://www.w3.org/2001/XMLSchema#string

Eric R Bates

http://www.w3.org/2001/XMLSchema#string

Gerald M Pohost

http://www.w3.org/2001/XMLSchema#string

Howard H Weitz

http://www.w3.org/2001/XMLSchema#string

P304

2250-2294

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.109.192230

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Harrison W Farber

David J Moliterno

Robert A Harrington

P577

2009-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19332472

http://www.w3.org/2001/XMLSchema#string

P921